Research and Markets (http://www.researchandmarkets.com/research/dm7s8l/pneumococcal) has announced the addition of the "Pneumococcal Meningitis-Pipeline Insights, 2016" report to their offering.

Pneumococcal Meningitis-Pipeline Insights, 2016 provides in depth insights on the pipeline drugs and their development activities around the Pneumococcal Meningitis. The report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.

Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details.

The report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Pneumococcal Meningitis.

The report also assesses the Pneumococcal Meningitis therapeutics by Monotherapy, Combination products, molecule type and Route of Administration.

Scope

  • The report provides competitive pipeline landscape of Pneumococcal Meningitis
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Pneumococcal Meningitis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Pneumococcal Meningitis and also provide company profiling
  • The report also gives the information of dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

  1. Pneumococcal Meningitis Overview
  2. Pneumococcal Meningitis Pipeline Therapeutics
  3. Pneumococcal Meningitis Therapeutics under Development by Companies
  4. Pneumococcal Meningitis Filed and Phase III Products
  5. Comparative Analysis
  6. Pneumococcal Meningitis Phase II Products
  7. Pneumococcal Meningitis Phase I and IND Filed Products
  8. Pneumococcal Meningitis Discovery and Pre-Clinical Stage Products
  9. Pneumococcal Meningitis - Therapeutics Assessment
  10. Assessment by Monotherapy Products
  11. Assessment by Combination Products
  12. Assessment by Route of Administration
  13. Assessment by Molecule Type
  14. Pneumococcal Meningitis - Discontinued Products
  15. Pneumococcal Meningitis - Dormant Products
  16. Companies Involved in Therapeutics Development for Pneumococcal Meningitis

For more information visit http://www.researchandmarkets.com/research/dm7s8l/pneumococcal